Effects of Anandamide on Polyamine Levels and Cell Growth in Human Colon Cancer Cells

Anandamide (AEA) is an endogenous agonist for cannabinoid receptor CB1-R and seems to be involved in the control of cancer growth. Polyamines are compounds that play an important role in cell proliferation and differentiation. Our aim was to investigate the effect of AEA on the polyamine levels (put...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Anticancer research 2010-07, Vol.30 (7), p.2583-2589
Hauptverfasser: LINSALATA, Michele, NOTARNICOLA, Maria, TUTINO, Valeria, BIFULCO, Maurizio, SANTORO, Antonietta, LAEZZA, Chiara, MESSA, Caterina, ORLANDO, Antonella, GABRIELLA CARUSO, Maria
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2589
container_issue 7
container_start_page 2583
container_title Anticancer research
container_volume 30
creator LINSALATA, Michele
NOTARNICOLA, Maria
TUTINO, Valeria
BIFULCO, Maurizio
SANTORO, Antonietta
LAEZZA, Chiara
MESSA, Caterina
ORLANDO, Antonella
GABRIELLA CARUSO, Maria
description Anandamide (AEA) is an endogenous agonist for cannabinoid receptor CB1-R and seems to be involved in the control of cancer growth. Polyamines are compounds that play an important role in cell proliferation and differentiation. Our aim was to investigate the effect of AEA on the polyamine levels (putrescine, spermidine and spermine) and cell growth of three human colon cancer cell lines, positive for CB1-R. After AEA treatment of DLD-1, HT-29 and SW620 cells, polyamine analysis was performed by high-performance liquid chromatography (HPLC) and cell growth was measured by 3-(4,5 di-methylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) test. CB1 gene expression was determined using reverse transcription and polymerase chain reaction (RT-PCR). AEA significantly reduced polyamine levels and cell proliferation dose-dependently when the tested cell lines were exposed for 24 h and 48 h. This inhibitory effect was mediated by CB1-R, since SR 1411716A, a selective CB-1 receptor antagonist, was able to entirely antagonize the effect of AEA. CB1-R mRNA levels were enhanced after AEA treatment in DLD-1 cells, whereas no induction was found in HT-29 and SW620 cells. It appears that mechanisms by which AEA may affect growth of colon cancer cells involve a decrease in cell proliferation rate by reducing the polyamine levels.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_748944730</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>748944730</sourcerecordid><originalsourceid>FETCH-LOGICAL-p240t-42dffd257b04c7fcb1c5f032ba7e801a69e9ea796b26cad68415a3af9c2f26b23</originalsourceid><addsrcrecordid>eNpF0F9LwzAQAPAgipvTryB5EZ8KaZLmz-Mo0wkDfXDP5ZomWEmT2bTKvr1BJz4dd_fjuLsztCylLgtZMXKOloRWpJCEVAt0ldI7IUJoxS7RghKhqFZiifYb56yZEo4OrwOEDoa-szgG_BL9MSfB4p39tD7h3MS19R4_jvFresN9wNt5gIDr6LOvIRg7_oh0jS4c-GRvTnGF9g-b13pb7J4fn-r1rjhQTqaC0865jlayJdxIZ9rSVI4w2oK0ipQgtNUWpBYtFQY6oXhZAQOnDXU0F9kK3f_OPYzxY7ZpaoY-mbwBBBvn1EiuNOeSkSxvT3JuB9s1h7EfYDw2f5_I4O4EIBnwbszn9OnfMSKVFpp9A62kZ3A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>748944730</pqid></control><display><type>article</type><title>Effects of Anandamide on Polyamine Levels and Cell Growth in Human Colon Cancer Cells</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>LINSALATA, Michele ; NOTARNICOLA, Maria ; TUTINO, Valeria ; BIFULCO, Maurizio ; SANTORO, Antonietta ; LAEZZA, Chiara ; MESSA, Caterina ; ORLANDO, Antonella ; GABRIELLA CARUSO, Maria</creator><creatorcontrib>LINSALATA, Michele ; NOTARNICOLA, Maria ; TUTINO, Valeria ; BIFULCO, Maurizio ; SANTORO, Antonietta ; LAEZZA, Chiara ; MESSA, Caterina ; ORLANDO, Antonella ; GABRIELLA CARUSO, Maria</creatorcontrib><description>Anandamide (AEA) is an endogenous agonist for cannabinoid receptor CB1-R and seems to be involved in the control of cancer growth. Polyamines are compounds that play an important role in cell proliferation and differentiation. Our aim was to investigate the effect of AEA on the polyamine levels (putrescine, spermidine and spermine) and cell growth of three human colon cancer cell lines, positive for CB1-R. After AEA treatment of DLD-1, HT-29 and SW620 cells, polyamine analysis was performed by high-performance liquid chromatography (HPLC) and cell growth was measured by 3-(4,5 di-methylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) test. CB1 gene expression was determined using reverse transcription and polymerase chain reaction (RT-PCR). AEA significantly reduced polyamine levels and cell proliferation dose-dependently when the tested cell lines were exposed for 24 h and 48 h. This inhibitory effect was mediated by CB1-R, since SR 1411716A, a selective CB-1 receptor antagonist, was able to entirely antagonize the effect of AEA. CB1-R mRNA levels were enhanced after AEA treatment in DLD-1 cells, whereas no induction was found in HT-29 and SW620 cells. It appears that mechanisms by which AEA may affect growth of colon cancer cells involve a decrease in cell proliferation rate by reducing the polyamine levels.</description><identifier>ISSN: 0250-7005</identifier><identifier>EISSN: 1791-7530</identifier><identifier>PMID: 20682986</identifier><language>eng</language><publisher>Attiki: International Institute of Anticancer Research</publisher><subject>Arachidonic Acids - pharmacology ; Biogenic Polyamines - metabolism ; Biological and medical sciences ; Cell Differentiation - physiology ; Cell Growth Processes - drug effects ; Colonic Neoplasms - drug therapy ; Colonic Neoplasms - metabolism ; Colonic Neoplasms - pathology ; Dose-Response Relationship, Drug ; Endocannabinoids ; Gastroenterology. Liver. Pancreas. Abdomen ; Gene Expression - drug effects ; HT29 Cells ; Humans ; Medical sciences ; Polyunsaturated Alkamides - pharmacology ; Receptor, Cannabinoid, CB1 - agonists ; Receptor, Cannabinoid, CB1 - biosynthesis ; Receptor, Cannabinoid, CB1 - genetics ; Receptor, Cannabinoid, CB1 - metabolism ; RNA, Messenger - biosynthesis ; RNA, Messenger - genetics ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus ; Tumors</subject><ispartof>Anticancer research, 2010-07, Vol.30 (7), p.2583-2589</ispartof><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23078969$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20682986$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>LINSALATA, Michele</creatorcontrib><creatorcontrib>NOTARNICOLA, Maria</creatorcontrib><creatorcontrib>TUTINO, Valeria</creatorcontrib><creatorcontrib>BIFULCO, Maurizio</creatorcontrib><creatorcontrib>SANTORO, Antonietta</creatorcontrib><creatorcontrib>LAEZZA, Chiara</creatorcontrib><creatorcontrib>MESSA, Caterina</creatorcontrib><creatorcontrib>ORLANDO, Antonella</creatorcontrib><creatorcontrib>GABRIELLA CARUSO, Maria</creatorcontrib><title>Effects of Anandamide on Polyamine Levels and Cell Growth in Human Colon Cancer Cells</title><title>Anticancer research</title><addtitle>Anticancer Res</addtitle><description>Anandamide (AEA) is an endogenous agonist for cannabinoid receptor CB1-R and seems to be involved in the control of cancer growth. Polyamines are compounds that play an important role in cell proliferation and differentiation. Our aim was to investigate the effect of AEA on the polyamine levels (putrescine, spermidine and spermine) and cell growth of three human colon cancer cell lines, positive for CB1-R. After AEA treatment of DLD-1, HT-29 and SW620 cells, polyamine analysis was performed by high-performance liquid chromatography (HPLC) and cell growth was measured by 3-(4,5 di-methylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) test. CB1 gene expression was determined using reverse transcription and polymerase chain reaction (RT-PCR). AEA significantly reduced polyamine levels and cell proliferation dose-dependently when the tested cell lines were exposed for 24 h and 48 h. This inhibitory effect was mediated by CB1-R, since SR 1411716A, a selective CB-1 receptor antagonist, was able to entirely antagonize the effect of AEA. CB1-R mRNA levels were enhanced after AEA treatment in DLD-1 cells, whereas no induction was found in HT-29 and SW620 cells. It appears that mechanisms by which AEA may affect growth of colon cancer cells involve a decrease in cell proliferation rate by reducing the polyamine levels.</description><subject>Arachidonic Acids - pharmacology</subject><subject>Biogenic Polyamines - metabolism</subject><subject>Biological and medical sciences</subject><subject>Cell Differentiation - physiology</subject><subject>Cell Growth Processes - drug effects</subject><subject>Colonic Neoplasms - drug therapy</subject><subject>Colonic Neoplasms - metabolism</subject><subject>Colonic Neoplasms - pathology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Endocannabinoids</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Gene Expression - drug effects</subject><subject>HT29 Cells</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Polyunsaturated Alkamides - pharmacology</subject><subject>Receptor, Cannabinoid, CB1 - agonists</subject><subject>Receptor, Cannabinoid, CB1 - biosynthesis</subject><subject>Receptor, Cannabinoid, CB1 - genetics</subject><subject>Receptor, Cannabinoid, CB1 - metabolism</subject><subject>RNA, Messenger - biosynthesis</subject><subject>RNA, Messenger - genetics</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><subject>Tumors</subject><issn>0250-7005</issn><issn>1791-7530</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpF0F9LwzAQAPAgipvTryB5EZ8KaZLmz-Mo0wkDfXDP5ZomWEmT2bTKvr1BJz4dd_fjuLsztCylLgtZMXKOloRWpJCEVAt0ldI7IUJoxS7RghKhqFZiifYb56yZEo4OrwOEDoa-szgG_BL9MSfB4p39tD7h3MS19R4_jvFresN9wNt5gIDr6LOvIRg7_oh0jS4c-GRvTnGF9g-b13pb7J4fn-r1rjhQTqaC0865jlayJdxIZ9rSVI4w2oK0ipQgtNUWpBYtFQY6oXhZAQOnDXU0F9kK3f_OPYzxY7ZpaoY-mbwBBBvn1EiuNOeSkSxvT3JuB9s1h7EfYDw2f5_I4O4EIBnwbszn9OnfMSKVFpp9A62kZ3A</recordid><startdate>20100701</startdate><enddate>20100701</enddate><creator>LINSALATA, Michele</creator><creator>NOTARNICOLA, Maria</creator><creator>TUTINO, Valeria</creator><creator>BIFULCO, Maurizio</creator><creator>SANTORO, Antonietta</creator><creator>LAEZZA, Chiara</creator><creator>MESSA, Caterina</creator><creator>ORLANDO, Antonella</creator><creator>GABRIELLA CARUSO, Maria</creator><general>International Institute of Anticancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20100701</creationdate><title>Effects of Anandamide on Polyamine Levels and Cell Growth in Human Colon Cancer Cells</title><author>LINSALATA, Michele ; NOTARNICOLA, Maria ; TUTINO, Valeria ; BIFULCO, Maurizio ; SANTORO, Antonietta ; LAEZZA, Chiara ; MESSA, Caterina ; ORLANDO, Antonella ; GABRIELLA CARUSO, Maria</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p240t-42dffd257b04c7fcb1c5f032ba7e801a69e9ea796b26cad68415a3af9c2f26b23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Arachidonic Acids - pharmacology</topic><topic>Biogenic Polyamines - metabolism</topic><topic>Biological and medical sciences</topic><topic>Cell Differentiation - physiology</topic><topic>Cell Growth Processes - drug effects</topic><topic>Colonic Neoplasms - drug therapy</topic><topic>Colonic Neoplasms - metabolism</topic><topic>Colonic Neoplasms - pathology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Endocannabinoids</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Gene Expression - drug effects</topic><topic>HT29 Cells</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Polyunsaturated Alkamides - pharmacology</topic><topic>Receptor, Cannabinoid, CB1 - agonists</topic><topic>Receptor, Cannabinoid, CB1 - biosynthesis</topic><topic>Receptor, Cannabinoid, CB1 - genetics</topic><topic>Receptor, Cannabinoid, CB1 - metabolism</topic><topic>RNA, Messenger - biosynthesis</topic><topic>RNA, Messenger - genetics</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>LINSALATA, Michele</creatorcontrib><creatorcontrib>NOTARNICOLA, Maria</creatorcontrib><creatorcontrib>TUTINO, Valeria</creatorcontrib><creatorcontrib>BIFULCO, Maurizio</creatorcontrib><creatorcontrib>SANTORO, Antonietta</creatorcontrib><creatorcontrib>LAEZZA, Chiara</creatorcontrib><creatorcontrib>MESSA, Caterina</creatorcontrib><creatorcontrib>ORLANDO, Antonella</creatorcontrib><creatorcontrib>GABRIELLA CARUSO, Maria</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Anticancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>LINSALATA, Michele</au><au>NOTARNICOLA, Maria</au><au>TUTINO, Valeria</au><au>BIFULCO, Maurizio</au><au>SANTORO, Antonietta</au><au>LAEZZA, Chiara</au><au>MESSA, Caterina</au><au>ORLANDO, Antonella</au><au>GABRIELLA CARUSO, Maria</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of Anandamide on Polyamine Levels and Cell Growth in Human Colon Cancer Cells</atitle><jtitle>Anticancer research</jtitle><addtitle>Anticancer Res</addtitle><date>2010-07-01</date><risdate>2010</risdate><volume>30</volume><issue>7</issue><spage>2583</spage><epage>2589</epage><pages>2583-2589</pages><issn>0250-7005</issn><eissn>1791-7530</eissn><abstract>Anandamide (AEA) is an endogenous agonist for cannabinoid receptor CB1-R and seems to be involved in the control of cancer growth. Polyamines are compounds that play an important role in cell proliferation and differentiation. Our aim was to investigate the effect of AEA on the polyamine levels (putrescine, spermidine and spermine) and cell growth of three human colon cancer cell lines, positive for CB1-R. After AEA treatment of DLD-1, HT-29 and SW620 cells, polyamine analysis was performed by high-performance liquid chromatography (HPLC) and cell growth was measured by 3-(4,5 di-methylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) test. CB1 gene expression was determined using reverse transcription and polymerase chain reaction (RT-PCR). AEA significantly reduced polyamine levels and cell proliferation dose-dependently when the tested cell lines were exposed for 24 h and 48 h. This inhibitory effect was mediated by CB1-R, since SR 1411716A, a selective CB-1 receptor antagonist, was able to entirely antagonize the effect of AEA. CB1-R mRNA levels were enhanced after AEA treatment in DLD-1 cells, whereas no induction was found in HT-29 and SW620 cells. It appears that mechanisms by which AEA may affect growth of colon cancer cells involve a decrease in cell proliferation rate by reducing the polyamine levels.</abstract><cop>Attiki</cop><pub>International Institute of Anticancer Research</pub><pmid>20682986</pmid><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0250-7005
ispartof Anticancer research, 2010-07, Vol.30 (7), p.2583-2589
issn 0250-7005
1791-7530
language eng
recordid cdi_proquest_miscellaneous_748944730
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Arachidonic Acids - pharmacology
Biogenic Polyamines - metabolism
Biological and medical sciences
Cell Differentiation - physiology
Cell Growth Processes - drug effects
Colonic Neoplasms - drug therapy
Colonic Neoplasms - metabolism
Colonic Neoplasms - pathology
Dose-Response Relationship, Drug
Endocannabinoids
Gastroenterology. Liver. Pancreas. Abdomen
Gene Expression - drug effects
HT29 Cells
Humans
Medical sciences
Polyunsaturated Alkamides - pharmacology
Receptor, Cannabinoid, CB1 - agonists
Receptor, Cannabinoid, CB1 - biosynthesis
Receptor, Cannabinoid, CB1 - genetics
Receptor, Cannabinoid, CB1 - metabolism
RNA, Messenger - biosynthesis
RNA, Messenger - genetics
Stomach. Duodenum. Small intestine. Colon. Rectum. Anus
Tumors
title Effects of Anandamide on Polyamine Levels and Cell Growth in Human Colon Cancer Cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T10%3A23%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20Anandamide%20on%20Polyamine%20Levels%20and%20Cell%20Growth%20in%20Human%20Colon%20Cancer%20Cells&rft.jtitle=Anticancer%20research&rft.au=LINSALATA,%20Michele&rft.date=2010-07-01&rft.volume=30&rft.issue=7&rft.spage=2583&rft.epage=2589&rft.pages=2583-2589&rft.issn=0250-7005&rft.eissn=1791-7530&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E748944730%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=748944730&rft_id=info:pmid/20682986&rfr_iscdi=true